JPMorgan Chase & Co. Boosts Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS)
JPMorgan Chase & Co. grew its position in Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) by 585.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 213,431 shares of the company’s stock after purchasing an additional 182,314 shares during the period. JPMorgan Chase & Co.’s holdings in Keros Therapeutics were worth $3,379,000 as of […]
JPMorgan Chase & Co. grew its position in Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) by 585.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 213,431 shares of the company’s stock after purchasing an additional 182,314 shares during the period. JPMorgan Chase & Co.’s holdings in Keros Therapeutics were worth $3,379,000 as of […]